Abstract
We studied the morbidity of chronic hepatitis Cin patients referred to a tertiary care medicalfacility. The medical records of 500 consecutive casesof chronic hepatitis C were examined for the following: (1) source and time of exposure, (2) signs andsymptoms of liver disease, (3) degree of alcohol intake,(4) liver biopsy findings, (5) extrahepatic diseasemanifestations, and (6) coexisting illnesses that could have an impact on morbidity. Morbidityand histologic findings were evaluated in relation tothe duration of hepatitis C. The onset of infectioncould be determined in 376 patients (75%). A close relationship between the length of infectionand disease features was not observed. Fatigue wascommon at all stages of infection. Whereas cirrhosisoccurred more frequently in patients with disease of long duration, 15-24% of patients had signs ofadvanced liver disease (ascites, encephalopathy,thrombocytopenia) within six years of exposure. Overtextrahepatic manifestations of chronic hepatitis Coccurred infrequently, and depression was reported in24% of untreated patients. In conclusion, in patientsreferred to a tertiary care setting, chronic hepatitisC is often associated with significantmorbidity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Dienstag JL: Non-A, non-B hepatitis: I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439–462, 1983
Seeff LB, Buskell-Bales Z, Wright EC, et al: Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906–1911, 1992
Alter HJ: Chronic consequences of non-A, non-B hepatitis. In LB Seeff, JH Lewis, (eds). New York, Plenum Medical, 1989, pp 83–97
Di Bisceglie AM, Goodman ZD, Ishak KG, et al: Long-term clinical and histological follow-up of chronic posttransfusion hepatitis. Hepatology 14:969–974, 1991
Realdi G, Alberti A, Rugge M, et al: Long-term follow-up of acute and chronic non-A, non-B hepatitis: Evidence of progression to liver cirrhosis. Gut 23:270–275, 1982
Koretz RL, Abbey H, Coleman E, et al: Non-A, non-B post-transfusion hepatitis: Looking back in the second decade. Ann Intern Med 119:110–115, 1993
Davis GL, Balart LA, Schiff ER, et al: Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile. Clin Ther 16:334–343, 1994
Dusheiko G, Schmilovitz-Weiss H, Brown D, et al: Hepatitis C virus genotypes: An investigation of type-specific difference in geographic origin and disease. Hepatology 19:13–18, 1994
Yoshioka K, Kakumu S, Wakita T, et al: Detection of hepatitis C virus by polymerase chain reaction and response to interferon alfa therapy: Relationship to genotypes of hepatitis C virus. Hepatology 16:293–299, 1992
Mendenhall C, Seeff L, Diehl AM, et al: Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis. Their prevalence and clinical relevance. Hepatology 14:581–589, 1991
Caldwell SH, Li X, Rourk RM, et al: Hepatitis C infection by polymerase chain reaction in alcoholics: False-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastgroenterol 88:1016–1021, 1993
Davis GL, Balart LA, Schiff ER, et al: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter, randomized, controlled trial. N Engl J Med 321:1501–1506, 1989
Pawlotsky JM, Ben Yahia M, Andre C, et al: Immunological disorders in C virus chronic active hepatitis: a prospective case control study. Hepatology 19:841–848, 1994
Lunel F, Musset L, Cacoub P, et al: Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300, 1994
Fargion S, Piperno A, Cappellini MD, et al: Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 16:1322–1326, 1992
Rebora A, Robert E, Rongioletti F: Clinical and laboratory presentation of lichen planus patients with chronic liver disease. J Dermatol Sci 4:38–41, 1992
Gray H, Wreghitt T, Stratton IM, et al: High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 12:244–249, 1995
Mason A, Lau JYN, Qian KP, et al: Association of diabetes mellitus with chronic hepatitis C virus (HCV) infection. Hepatology 22:351A, 1995 (abstract)
Taruschio G, Santarini F, Sica G, et al: psychiatric disorders in hepatitis C virus related chronic liver disease. Gastroenterology 110:A1342, 1996 (abstract)
Rights and permissions
About this article
Cite this article
Lee, D.H., Jamal, H., Regenstein, F.G. et al. Morbidity of Chronic Hepatitis C as Seen in a Tertiary Care Medical Center. Dig Dis Sci 42, 186–191 (1997). https://doi.org/10.1023/A:1018818012378
Issue Date:
DOI: https://doi.org/10.1023/A:1018818012378